Monthly Archives - September 2020

XYLYX BIO launches specialized contract R&D services that increase predictiveness in antifibrotic drug discovery

Xylyx Bio, a leader in advanced disease models for drug discovery, today announced the launch of specialized contract R&D services that support improved assessment of antifibrotic drug candidate efficacy. Despite ongoing advances, the current drug discovery paradigm is highly inefficient. Read more >>
Read more...

The 100 People You Don’t Know But Should 2020

Sue Nolin VP, Inside Sales, Wasabi Technologies -- When it comes to growing sales and its channel team, Wasabi turns to Nolin. She is constantly working to up the cloud storage vendor’s game when it comes to supporting solution providers’ sales efforts every day. She knows the channel is key to her and Wasabi’s success. Read more >>
Read more...

Cognoptix Revitalizes, Appoints New Chief Executive Officer Dr. Susanne Wilke, PhD, Raises Oversubscribed $2.6m Series R

Cognoptix, a healthcare company developing the Sapphire II System, a breakthrough technology for early detection of Alzheimer's disease (AD), announces the closing of an over-subscribed Series R financing round. Cognoptix has undergone a complete revitalization over the past year. Read more >>
Read more...

Seattle gene therapy biotech startup Immusoft raises $4.5M

Seattle-based biotech startup Immusoft raised another $4.5 million and landed a $467,000 NIH grant to help further development of its drugs that treat genetic diseases. Founded in 2009, Immusoft develops immune cell technology that uses blood cells from a patient to create therapeutic proteins targeted to treat diseases. Its lead candidate, ISP-001, treats Mucopolysaccharidosis type I, or MPS I, and has both orphan drug and rare pediatric disease designations from the FDA. Read more >>
Read more...

ZetrOZ Systems’ Sam® Technology Provides Safer Alternative to Opioids for Pain Management

Instead of turning to potentially addictive and dangerous opioid medications, individuals suffering from chronic pain can now leverage the power of ZetrOZ Systems' Sustained Acoustic Medicine (sam®) technology to accelerate natural healing. sam® has been funded by the U.S. federal government to treat chronic pain and reduce the need for surgeries. Read more >>
Read more...

BostInno – BostInno’s 25 Under 25: These are 2020’s brightest young minds

Seems that you're never too young, either. Boston teen and college-age technologists and entrepreneurs are living that mantra, founding companies, publishing books and working as venture capitalists without waiting for anyone's permission. We looked across the Bay State to find some of today's brightest young minds—and honor them through our annual awards list, 25 Under 25. Read more >>
Read more...

USA-Based ZetrOZ Systems Selected by the National Institute of Aging to Present the Sustained Acoustic Medicine (SAM) Medical Product Portfolio to Global Healthcare Community

ZetrOZ Systems, a leading USA-based medical device manufacturer, was selected by the National Institute of Aging to present its product portfolio on opioid/surgery free medical technology, also known as Sustained Acoustic Medicine, or SAM®.
Read more...

FYZICAL Therapy and Balance Centers El Paso Brings New Technology to its Clinics to Support Patients Faced With Knee Pain

FYZICAL Therapy and Balance Centers – El Paso, announces today the launch of KneeKGTM into all four of their locations. Developed by Emovi, the KneeKG is for the knee, like an EKG is for the heart and provides valuable data that enables physicians and other healthcare professionals to determine the most appropriate patient-specific care plan to restore optimal knee function. Read more >>
Read more...